Skip to main content
Annals of Intensive Care
Fig. 2 | Annals of Intensive Care

Fig. 2

From: Broadening the Berlin definition of ARDS to patients receiving high-flow nasal oxygen: an observational study in patients with acute hypoxemic respiratory failure due to COVID-19

Fig. 2

A 28-day survival and B cumulative incidence of liberation of respiratory support in patients receiving HFNO compared to patients receiving ventilation. For survival the adjusted hazard ratio is shown. A shows survival in the first 28 days, and B shows survival until the day of extubation. The cumulative incidence of liberation from respiratory support is shown as unadjusted hazard ratio with center as random effect. CI confidence interval, HFNO high-flow nasal oxygen, HR hazard ratio

Back to article page